Longport develops, manufactures, markets, and sells high resolution ultrasound imaging systems. Our imaging system, the EPISCAN I-200, can have connected to it a range of interchangeable imaging probes that enable the imaging of the skin and underlying soft tissue at frequencies between 20 and 50MHz.
Our products are developed for point-of-care use, meaning they are primarily expected to be used by the clinician who is seeking the diagnostic data.
The EPISCAN has gained FDA and CE marketing clearance.
The Company's technology is being utilized in broad range of applications including the following market sectors:
- Wound assessment and prevention
- Research, including validation of processes and products that impact the skin
Longport is dedicated to further extending its technology, product, and application base and to the validation of the use of high resolution ultrasound in a broad range of emerging markets.